Skip to content
a16za16z

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years. Timestamps: 0:00—Introduction 1:15—The Health Awakening, Explained 7:02—MAHA's Role in the Health Movement 13:05—GLP-1: Nearly One in Seven Americans 18:37—The Non-GLP Peptide Craze 25:16—Rogue Experiments and Low-Dose GLP 31:40—Real-Time Cortisol Sensing 44:39—The Pet Octopus and AI Communication Resources: Follow Andrew Huberman on X: https://twitter.com/hubermanlab Follow Daisy on X https://twitter.com/daisydwolf Stay Updated: If you enjoyed this episode, be sure to like, subscribe, and share with your friends! Find a16z on X: https://twitter.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Listen to the a16z Show on Spotify: https://open.spotify.com/show/5bC65RDvs3oxnLyqqvkUYX Listen to the a16z Show on Apple Podcasts: https://podcasts.apple.com/us/podcast/a16z-podcast/id842818711 Follow our host: https://x.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see http://a16z.com/disclosures.

Dr. Andrew HubermanguestDaisy Wolfhost
Mar 8, 202650mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Huberman on self-directed health, peptides, sleep tech, and AI future

  1. Huberman argues that COVID-era mortality salience, distrust in institutions, and accessible tools like vitamin D, fitness supplements, and circadian protocols pushed people toward self-directed health management.
  2. He describes GLP-1 drugs (including next-generation agents like retatrutide) as potentially society-wide obesity reducers, predicting broad adoption alongside a growing gray/compounded-market ecosystem and lower-dose experimentation.
  3. He cautions that the broader peptide boom (e.g., BPC-157, pinealon, growth hormone secretagogues, melanotan) is outpacing human evidence, creating sourcing, contamination, and tumor-growth risk considerations.
  4. He frames the next wave of health innovation as moving from “reading” biology (wearables, biomarkers, AI triage) to “writing” biology (targeted sleep/circadian state control, noninvasive neural modulation, and personalized interventions).
  5. He contends AI can summarize advice but behavior change improves when people learn mechanisms, and he closes by outlining an AI-driven attempt to decode octopus cognition via camouflage pattern analysis rather than training animals to mimic humans.

IDEAS WORTH REMEMBERING

5 ideas

The “health awakening” was catalyzed by COVID plus accessible, actionable health tools.

Huberman credits pandemic-driven mortality awareness and institutional distrust, combined with widely discussed interventions (vitamin D, resistance training, protein/creatine, circadian routines), for making people feel personally responsible for their health outcomes.

Circadian alignment is a major lever for mental health—bright days and dark nights matter.

He cites large-scale evidence that dim daytime light and bright nights worsen many psychiatric conditions, and emphasizes practical interventions like morning light exposure and using long-exhale breathing to acutely reduce arousal.

GLP-1s may normalize “healthy weight” the way credit normalized “nice cars.”

He predicts widespread GLP adoption—possibly over half of Americans in some groups—driven by efficacy (up to ~1/3 bodyweight loss), lower-dose self-experimentation, and access via compounding/gray markets, while noting resistance training is important to mitigate muscle loss.

Peptide enthusiasm is outrunning evidence; risk is often about growth signaling and sourcing.

For compounds like BPC-157 and pinealon, he highlights limited human data and the theoretical danger of stimulating unwanted cell growth (e.g., tumor vascularization/proliferation), plus contamination risk (e.g., endotoxin) from repeat injections of less-regulated products.

Not all “peptide markets” are equal—black market, gray market, compounding, and pharma differ materially.

He distinguishes black-market purchases (unknown contents) from gray-market “research only” vendors (often with stated purity/COAs but still contamination concerns), compounding pharmacies (variable oversight), and branded pharma (highest assurance, highest price, often higher standard dosing).

WORDS WORTH SAVING

5 quotes

Whether you were pro-vaccine, vaccine skeptical, or anti-vax, what became very clear is everyone realized, some bell went off, we are all responsible for our own health.

Dr. Andrew Huberman

The brighter people's days are and the darker their nights, the healthier they are mentally.

Dr. Andrew Huberman

You get that [big morning cortisol pulse, then trough in the late afternoon] and you win 90% of the game.

Dr. Andrew Huberman

You don't wanna stimulate the sympathetic nervous system so much for so often. It can probably shorten your life.

Dr. Andrew Huberman

I'm interested in what the octopus understands about the world and can communicate that to me because I don't know that stuff. I can learn to play a piano. Why would I wanna teach an octopus to play a piano? That's silly.

Dr. Andrew Huberman

Drivers of the health awakening (COVID, fitness mainstreaming, supplements)Circadian biology, mental health, and simple downregulation tools (long exhales)MAHA, media polarization, and maintaining scientific independenceGLP-1s/retatrutide adoption, compounding pharmacies, and gray marketsNon-GLP peptides: BPC-157, pinealon, growth hormone secretagogues, melanotanFocus/alertness pharmacology (stimulants, modafinil, Sunosi) and sympathetic costRead vs. write health tech: sleep actuation, cortisol sensing, noninvasive brain-state control

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.

Add to Chrome